1

Indoco Remedies

#7637

Rank

$346.89M

Marketcap

IN India

Country

Indoco Remedies
Leadership team

Mr. Suresh Govind Kare (Exec. Chairman)

Mr. Sundeep Vasant Bambolkar (Joint MD & Exec. Director)

Ms. Aditi Milind Panandikar (MD & Exec. Director)

Products/ Services
Medical, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Mumbai, Maharashtra, India
Established
1947
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
INDOCO.NS
Overview
Location
Summary
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. The company's products portfolio includes respiratory products, such as Karvol Plus, Febrex Plus, Dropizin, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Sensodent-KF, Poviclean, Rexidin, Sensodent-R, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclopam Plus, Cyclomeff, and Nosic; pain/analgesics products that include Lignox A and Lignox ; and ophthal/otologicals products, such as Renolen, Homide, Dexoren ? S, Zincoren, Bfloren, Dexoren, Otorex, Mofloren-D, Mofloren ? BF, Macuchek, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Coloferrin, Cal Aid, and MCBM DHA; urology products, such as Cital-H and Cital; Cloben G, Noxa, and Scabex for dermatology; ATM, Clygan, Vepan, and Oxipod for anti-infectives; Hemsyl for blood related therapies; MCBM 69 and D-Chiro for gynecological; Aloja and Aloja M for Anti-Diabetics; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
History

The late Shri. I.C. Chopra founded Indoco Remedies in 1933 to meet the needs of the Indian pharmaceuticals market. The company began its journey with the production of the antibacterial drug Sulphanilamide. In the ensuing years, the company diversified into a range of therapeutic areas, including antibiotics and has developed a wide portfolio of generic pharmaceuticals.

Mission
We are driven to develop, manufacture and market quality pharmaceutical products that meet or exceed international standards, while striving to be a preferred partner to our customers and employees.
Vision
Our vision is to become the leading healthcare solutions provider in India and abroad by providing quality products with the highest level of customer service and value.
Key Team

Mr. Pramod Ghorpade (Chief Financial Officer)

Mr. A. S. Rege (Pres of Operations)

Dr. Kavita Inamdar (Chief Technical Officer)

Mr. Ramanathan Hariharan (GM of Legal, Company Sec. & Compliance Officer)

Mr. Bandari Rajendra Kumar (Sr. VP of Marketing)

Mr. Sunil D. Joshi (Pres of Fin.)

Mr. Vilas V. Nagare (Pres of Corp. Affairs and M&A)

Recognition and Awards
Indoco Remedies have received numerous awards over the years, including the ‘India Excellence Award’ for 2013-14, the ‘Pharma Professional of the Year’ in 2016, and the 'Vaccine Manufacturer of the Year 2016 Award' from the Indian Government.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Indoco Remedies
Leadership team

Mr. Suresh Govind Kare (Exec. Chairman)

Mr. Sundeep Vasant Bambolkar (Joint MD & Exec. Director)

Ms. Aditi Milind Panandikar (MD & Exec. Director)

Products/ Services
Medical, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Mumbai, Maharashtra, India
Established
1947
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
INDOCO.NS